Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View

Dr. Sarah Premji

Breast Oncology

View

Dr. Roberto Leon-Ferre

Breast Oncology · Mayo Clinic College of Medicine

View

Dr. Nerea Lopetegui-Lia

Breast Oncology · OSUMC

View

Dr. Allison Kurian

Breast Oncology · SU

View

Dr. Minhtri Nguyen

Breast Oncology · Advisor

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    APDr. Ann Partridge

    Dr. Ann Partridge

    Medical Oncology · Breast Oncology
    Dana-Farber Cancer Institute
    annp

    Research

    Postpartum breast cancer: evidence for a distinct phenotype

    2026

    Via Journal of the National Cancer Institute

    Research

    Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer

    2026

    Via The Breast

    Research

    Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study

    2026

    Via Journal of Clinical Oncology

    Research

    From a cancer survivorship-focused continuing medical education course to practice change implementation: results of a provider survey

    2026

    Via Journal of Cancer Survivorship

    Research

    Tumor genomics in patients younger than 40 years of age with metastatic breast cancer

    2026

    Via NPJ Precision Oncology

    Research

    Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

    2025

    Via The Breast

    Research

    Fertility preservation and mental health among cancer patients of reproductive age

    2025

    Via Fertility and Sterility

    Research

    Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial

    2025

    Via JAMA Oncology

    Research

    Breastfeeding after breast cancer in young BRCA carriers

    2025

    Via Journal of the National Cancer Institute

    Research

    Combined intermittent fasting and exercise intervention in patients with metastatic, hormone receptor-positive breast cancer (FastER): a pilot study

    2025

    Via Breast Cancer Research and Treatment

    Research

    Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort

    2025

    Via Journal of the National Cancer Institute

    Research

    Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

    2025

    Via Nature Communications

    Jul 27, 2025Journal Article

    Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study.

    ​
    ​

    Written by 2 Roon authors & 16 others

    Via Annals of Surgical Oncology

    Research

    Fertility preservation and fertility treatment use in young breast cancer survivors reporting a live birth

    2025

    Via Fertility and Sterility

    Research

    Association of cancer treatment with excess heart age among five-year young breast cancer survivors

    2024

    Via Journal of Cancer Survivorship